Avita Medical | 1811094D - Bénéfice Avant Impôts





Bénéfice Avant Impôts Changement Date
Accuray USD 3.23M 6.56M 2024-12
Celltrion KRW 11.84B 1.34B 2026-03
Clinuvel Pharmaceuticals AUD 28.8M 6.9M 2025-06
Cochlear AUD 121.1M 155.6M 2025-06
CSL USD 2.61B 1.21B 2025-12
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
Dianthus Therapeutics USD -40.83M 23.6M 2026-03
Divis Laboratories Ltd INR 11.8B 2.17B 2026-06
Kangmei Pharma CNY -14.01M 16.08M 2026-03
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
Mayne Pharma AUD -14.7M 42.91M 2024-12
Medical Developments International AUD -149K 466K 2025-06
Nanosonics AUD 11.39M 487K 2025-06
Neuren Pharmaceuticals AUD 19.21M 9.35M 2025-12
Organigram Holdings CAD -921K 40.8M 2026-03
Pacific Edge NZD -714K 49K 2024-03
Pharma Mar EUR -993K 2.59M 2026-06
Polynovo AUD 1.96M 146K 2025-12
PYC Therapeutics AUD -12.57M 13.3M 2025-06
Qiagen NV USD 157.9M 72.08M 2026-06
Ramsay Health Care AUD 240.5M 136.75M 2025-12
ResMed USD 502.31M 6.16M 2026-03
Sartorius EUR 127M 30.8M 2026-06
Telix Pharmaceuticals AUD 76.73M 66.04M 2025-06
Tilray USD -39.96M 39.19M 2025-09
Zealand Pharma A/S -394M 12.5M 2026-03
Zz Pientze Pharmaceu CNY 876.07M 352.96M 2026-03